Lazard Asset Management »

Genes shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Genes (GCO) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $256k 9.4k 27.14
2022-06-30 $26k 521 49.90
2022-03-31 $45k 708 63.56
2021-12-31 $32k 502 63.75

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Intercontinen Common Stock (ICE)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Exelon Corp Common Stock (EXC)
Aon Plc/ireland Common Stock (AON)
Exxon Mobil Common Stock (XOM)
Broadcom Common Stock (AVGO)

View all positions for Lazard Asset Management

Top funds holding Genes

Pzena Investment Management
BlackRock
BlackRock
Alliancebernstein
Dimensional Fund Advisors
Vanguard Group
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
State Street Corporation
Arrowstreet Capital, Limited Partnership
Jpmorgan Chase & Co
Geode Capital Management
Charles Schwab Investment Management
American Century Companies

View all funds holding Genes